Rate My Professor Carl Schneider

Schneider's research specializations center on pharmacy practice, medicines optimisation, quality use of medicines (QUM), improvement science, patient safety, and health services research, with particular emphasis on optimizing medication management for aging populations and at care transitions. He currently supervises ten PhD students and has successfully overseen more than 30 Master of Pharmacy student research projects. In leadership capacities, he acts as Secretary of the Academic Section of the International Pharmaceutical Federation (FIP) and Associate Editor for Research in Social and Administrative Pharmacy. His scholarly output has garnered over 3,157 citations on Google Scholar, reflecting an h-index of 31 and substantial impact in the field. Key publications include 'Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive analysis of hospitalisations' (2017, British Journal of Clinical Pharmacology), 'Measuring and assessing the competencies of preceptors in health professions: a systematic review' (2020), 'The provision of advice by pharmacy staff in eastern Indonesian primary care settings: a simulated patient study' (2019), 'Implementability of opioid deprescribing interventions at transitions of care: a theory-informed exploratory qualitative study' (2024, British Journal of Clinical Pharmacology), and 'Barriers and enablers to implementing opioid deprescribing interventions at transitions of care: an Australian multi-site qualitative study' (2025). His work has informed University of Sydney-led guidelines on safer opioid deprescribing and studies linking pharmacist quality of care to medication adherence.